Singapore, Feb. 25 -- Agilus Diagnostics, India's largest diagnostic company and Lucence, a global pioneering molecular diagnostics company, have entered into a strategic collaboration to advance cancer diagnostics and personalised medicine in India.

This collaboration will integrate Singapore-based Lucence's cutting-edge molecular testing technologies into Agilus' extensive laboratory network, offering enhanced cancer detection, treatment selection, and monitoring capabilities.

Through this collaboration, Agilus Diagnostics will integrate Lucence's advanced molecular testing solutions into its comprehensive oncology diagnostics portfolio. LiquidHALLMARK is an ultra-sensitive, next-generation sequencing liquid biopsy that analyses circu...